|
Philips Healthcare is voluntarily recalling some of its HeartStart FR2+ automated external defibrillators (AED), with the knowledge of the appropriate regulatory agencies.
Written by Chris Knight
How do you realize the value of a human life? There are many ways really, but for me the true clarity came from my death. Yes, that’s right, I died; five times to be exact. My name is Chris Knight, and because of a miraculous second chance at life, I am taking this opportunity to share with you my story.
Royal Philips Electronics has signed a contract to become a medical equipment supplier of the New York Yankees, providing the team with onsite digital x-ray and automated external defibrillators.
Physio-Control, a wholly owned subsidiary of Medtronic, has received clearance from the FDA to market its Lifepak 15 monitor/defibrillator within the U.S.
|
Traditional hospital factors--such as case volume and academic status--do not appear to predict whether patients with cardiac arrest at that facility are likely to experience delays in receiving defibrillation, according to a large registry study in the July 27 issue of Archives of Internal Medicine.
The U.S. House of Representatives has passed the “Josh Miller HEARTS Act,” (H.R. 1380), legislation that establishes a federal grant program to help fund the placement of automated external defibrillators (AEDs) at elementary and secondary schools across the country. While also requiring school personnel to receive training in the operation of AEDs, the legislation will increase public awareness of sudden cardiac arrest (SCA) and the importance of AEDs in schools.
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has received clearance from the State Food and Drug Administration (SFDA) of China to market and sell its R Series Code-Ready defibrillators to hospitals in the People's Republic of China.
The FDA and Welch Allyn have notified healthcare professionals and consumers of a nationwide Class I recall of 14,054 automatic external defibrillator (AED) 10 and MRL JumpStart AEDs manufactured between Oct. 3, 2002 and Jan. 25, 2007.
|
RSS 
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.
There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.